Mouse Model for Eye Disease Research
Author Information
Author(s): Riya R. Paranthan, Paola Bargagna-Mohan, Daniel L. Lau, Royce Mohan
Primary Institution: University of Kentucky
Hypothesis
To develop an animal model for simultaneously eliciting corneal angiogenesis and retinal gliosis that will enable the assessment of inhibitor efficacy on these two pathological processes in separate anatomic sites of the ocular globe.
Conclusion
The study successfully developed a mouse model that allows for the investigation of both retinal gliosis and corneal neovascularization, demonstrating the inhibitory effects of withaferin A on these processes.
Supporting Evidence
- The model allows for the simultaneous study of two distinct ocular pathologies.
- Withaferin A treatment significantly inhibited corneal neovascularization.
- Retinal gliosis was associated with increased GFAP expression, which was downregulated by WFA.
Takeaway
Researchers created a special mouse model to study eye diseases, which helps them test new treatments for problems like swelling and new blood vessel growth in the eye.
Methodology
Mice were subjected to alkali burn injury and treated with withaferin A or vehicle to assess the effects on corneal neovascularization and retinal gliosis over 14 days.
Limitations
The model may not fully replicate human disease conditions and responses may vary across different mouse strains.
Participant Demographics
C57BL/6J mice, aged four to six weeks.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website